Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2020-01-01
2022-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Topical 5-ALA Photodynamic Therapy for the Treatment of Verruca Vulgaris
NCT00155584
A Randomized Controlled Trial to Evaluate the Effectiveness of Bleomycin and Cryotherapy in Treating Plantar Warts.
NCT06718192
Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Small Genital Warts
NCT03948321
Intralesional Treatment of Plantar Wart
NCT05057663
Intralesional Acyclovir Versus Cryotherapy in the Treatment of Plantar Warts. A Randomized Controlled Trial.
NCT06261684
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Eighty patients suffering of verruca (male and female) divided randomly into three groups: group A, B\&C :
Group A: 30 patients will undergo photodynamic therapy using intralesional 4%methylene blue solution and IPL.
Group B: 30 patients will undergo IPL only. Group C (control group):20 patients will undergo intralesional saline.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
methylene blue/IPL
will undergo photodynamic therapy using intralesional 4%methylene blue solution ,after a period of 15 minutes the patient will be subjected to IPL session.
This will be repeated biweekly until complete clearance of the lesion or a maximum four sessions.
methylene blue / IPL
therapeutic
IPL
will undergo biweekly IPL sessions only until complete clearance of the lesion or a maximum four sessions.
IPL
therapeutic
saline
will undergo intralesional saline.
saline
placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
methylene blue / IPL
therapeutic
IPL
therapeutic
saline
placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Sex:Both males and female patients.
3. Clinically and dermoscopically documented verruca.
4. No verruca treatment in the last 2 weeks.
Exclusion Criteria
2. Pregnant and lactating females.
3. Diseases with risk of koebnerization e.g. Psoriasis and Lichen planus.
4. Anogenital warts.
5. Warts on head and neck.
16 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alexandria University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
marwa eldeeb
lecturer of dermatology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alexandria University Faculty of Medicine
Alexandria, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0106171
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.